Judge Questions Difference Between Hegseth's Testosterone Policy and Transgender Care Policy for Troops
Judge Ana Reyes ordered the Pentagon to explain why its testosterone screening plan differs from hormone treatment for transgender troops.
- On Wednesday, U.S. District Judge Ana Reyes questioned the Pentagon's new testosterone replacement therapy initiative, ordering both parties in a lawsuit challenging the military's transgender troop ban to compare how TRT is administered to transgender troops versus other service members.
- Defense Secretary Pete Hegseth announced last week that the Pentagon will conduct annual testosterone screenings for service members aged 30 and older, offering voluntary treatment to those with low levels, calling it necessary for troops to operate at their "absolute best."
- Transgender active-duty service members sued the administration in January 2025, alleging the military ban violates due process. Reyes granted the case class-action status, meaning the court's ruling could affect all service members challenging the policy.
- Reyes ordered both parties to address the medical and logistical similarities between the new TRT policy and the military ban in upcoming briefs. She requested information on the Pentagon's basis for treating transgender troops differently from other service members.
- Although a federal appeals panel partially upheld Reyes's rulings last year, the transgender military ban remains in effect. The Supreme Court has allowed the Pentagon to enforce the policy while litigation continues in the lower courts.
33 Articles
33 Articles
The U.S. government views scientific evidence as an optional and flexible servant at the service of the most vital issue: masculinity
Military Doctors Say Hegseth's Testosterone Plan Skips the Serious Side Effects Discussion
Hegseth's July 15 testosterone screening mandate for military members over 30 drew immediate concern from doctors about infertility, stroke risk, and lack of medical justification. Here is what the evidence shows.
Pete Hegseth has a sperm-count problem: medical experts
Defense Secretary Pete Hegseth’s controversial plan to test service members’ testosterone levels may end up having an ironic side effect on male soldiers, two medical experts said in a new report. Dr. Adrian Dobs, a professor of medicine and oncology at John Hopkins University School of Medicine explained the issue to The Intercept Friday.“We’re sort of creating a dependency on testosterone,” Dobs said. “Men who take testosterone will have a red…
Hegseth’s Testosterone Plan Faces Scrutiny in Transgender Troop Case
WASHINGTON, D.C. — A federal judge has ordered the Pentagon to explain why it is promoting testosterone treatment for some service members while citing hormone therapy as a reason to exclude transgender troops. Defense Secretary Pete Hegseth recently announced that active-duty and reserve personnel aged 30 and older will now receive annual screenings for testosterone deficiency. Those found to have low levels can choose to undergo testosterone r…
Judge Questions Pentagon Testosterone vs Trans Troop Policy
Defense Secretary Pete Hegseth's new initiative screening troops for low testosterone has opened an unexpected legal front, a federal judge now demands the Pentagon explain why hormone therapy is fit for some service members but not others. U.S. District Judge Ana C. Reyes issued an order directing both sides in Talbott v. Trump to address whether Hegseth's "High-T" testosterone replacement therapy program contradicts the government's own argume…
Coverage Details
Bias Distribution
- 39% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
